MAGN:NYSEMagnera Corporation Analysis
Data as of 2026-04-16 - not real-time
$10.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Magnera (MAGN) trades at $10.6, comfortably above its 20‑day SMA of $9.63 but below the 50‑day ($11.63) and 200‑day ($12.13) averages, indicating a short‑term price advantage yet a longer‑term bearish bias. The stock sits near the technical resistance of $10.89 and above the near‑term support of $8.71, while the RSI of 53.8 suggests neutral momentum and the MACD histogram turning positive signals a potential short‑term bounce. However, volume is on a decreasing trend and the 30‑day volatility is high at 52%, compounded by a beta of 1.62, reflecting pronounced price swings relative to the market.
Fundamentally, MAGN is heavily leveraged (debt‑to‑equity ≈ 192) and posted a negative profit margin of –4%, yet it generates positive operating and free cash flow and projects a forward EPS of $0.91. The DCF fair value of $64.04 and a target price of $14 imply a 32% upside from current levels, while the price‑to‑book of 0.37 underscores deep value relative to its book. Analyst consensus is a “hold” amid extreme market greed (Fear‑Greed Index ≈ 89), suggesting caution despite the attractive valuation metrics.
Fundamentally, MAGN is heavily leveraged (debt‑to‑equity ≈ 192) and posted a negative profit margin of –4%, yet it generates positive operating and free cash flow and projects a forward EPS of $0.91. The DCF fair value of $64.04 and a target price of $14 imply a 32% upside from current levels, while the price‑to‑book of 0.37 underscores deep value relative to its book. Analyst consensus is a “hold” amid extreme market greed (Fear‑Greed Index ≈ 89), suggesting caution despite the attractive valuation metrics.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish longer‑term trend (price below SMA50/200)
- Decreasing volume and high 30‑day volatility
- Technical proximity to resistance at $10.89
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation upside (target $14, DCF $64)
- Positive cash flow generation despite earnings loss
- Forward EPS turning positive
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Deep discount to book value (P/B ≈ 0.37)
- Revenue growth of ~13% YoY in a defensive consumer sector
- Potential balance‑sheet improvement as cash offsets part of debt
Key Metrics & Analysis
Financial Health
Revenue Growth12.80%
Profit Margin-4.04%
P/E Ratio11.6
ROE-12.41%
ROA1.90%
Debt/Equity192.00
P/B Ratio0.4
Op. Cash Flow$163.0M
Free Cash Flow$172.1M
Technical Analysis
TrendBearish
RSI53.8
Support$8.71
Resistance$10.89
MA 20$9.63
MA 50$11.63
MA 200$12.13
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98
Valuation
Fair Value$64.04
Target Price$14.00
Upside/Downside32.08%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.62
Volatility52.24%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.